FDA Inspection 1221056 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on Aug 31, 2023 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 31, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shreveport, LA (United States)